News

A.P. Møller - Mærsk A/S Launches Share Buy-Back Initiative

A.P. Møller - Mærsk A/S Launches Share Buy-Back Initiative

Share Buy-Back Program Overview

A.P. Møller - Mærsk A/S has announced an ambitious share buy-back program, underlining the company's commitment to enhancing shareholder value. This initiative involves a prospective total investment of around DKK 14.4 billion, which is equivalent to approximately USD 2 billion. The program will be conducted over a span of 12 months, allowing for a systematic approach to share acquisitions.

Execution Timeline and Purchase Details

The first phase of the share buy-back program is set to commence from 7 February, continuing until 6 August. During this initial phase, the acquisition will be capped at a total market value of DKK 7.2 billion, approximately USD 1 billion. Such a structured timeline allows the company to manage and optimize its acquisitions effectively.

Recent Transactions Under the Program

From 7 February to 14 February, A.P. Møller - Mærsk A/S executed several notable transactions. The current trajectory suggests a robust start to the share buy-back efforts:

  • On 7 February, 950 A shares were purchased at an average price of 11,130.2526 DKK, totaling 10,573,740 DKK.
  • The following days saw similar transactions, with 950 shares purchased daily until 13 February.
  • On 14 February, the company acquired 734 A shares at an average price of 11,735.6948 DKK, bringing in a total transaction value of 8,614,000 DKK.

In total, during this period, 5,484 A shares were acquired, resulting in a combined transaction value of 63,488,260 DKK.

B Share Transactions and Total Accumulation

Alongside A shares, the transactions for B shares also reflect a strong commitment to the buy-back program. From 7 February to 14 February, the following activities were noted:

  • Initially, 4,760 B shares were purchased on 7 February at 11,363.2069 DKK per share.
  • As with A shares, the program maintained consistency with daily purchases, completing the period with a total of 27,074 B shares acquired, resulting in a total value of 320,174,820 DKK.

The culmination of these efforts results in an overall accumulation of 30,617 shares (both A and B) under the buy-back program. This substantial commitment reflects the strategic vision of A.P. Møller - Mærsk A/S in optimizing shareholder returns.

Shareholder Participation and Future Outlook

The share buy-back program extends beyond mere numerical transactions. A.P. Møller - Mærsk A/S collaborates with its familial foundation, A.P. Møller og Hustru Chastine Mc-Kinney Møllers Familiefond, to ensure a pro-rata acquisition of shares, emphasizing the interconnectedness of stakeholder interests. This aligns well with the company’s broader objectives of maintaining a healthy and responsive market environment.

Concluding Thoughts and Contact Information

With the implementation of this buy-back program, A.P. Møller - Mærsk A/S demonstrates its unwavering commitment to enhancing shareholder value and executing financial strategies with precision. Investors and stakeholders alike can look forward to continuous updates as this program progresses.

For further inquiries or more detailed discussions regarding this initiative, please reach out to:

Head of Investor Relations: Stefan Gruber, tel. +45 3363 3484
Head of Media Relations: Jesper Lov, tel. +45 6114 1521

Frequently Asked Questions

What is the total investment planned for the buy-back program?

The total investment planned for the share buy-back program is approximately DKK 14.4 billion, which is around USD 2 billion.

How long will the share buy-back program last?

The program is set to be executed over a period of 12 months, starting from February 7.

How many shares were acquired from February 7 to February 14?

During this period, a total of 5,484 A shares and 30,617 shares in total were acquired.

Who participates in the share buy-back program?

The A.P. Møller og Hustru Chastine Mc-Kinney Møllers Familiefond participates pro-rata in the share acquisitions made under the buy-back program.

What is the purpose of this buy-back program?

This program aims to enhance shareholder value by reducing the number of shares available in the market and consolidating ownership.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 193

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 255

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 129

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 372

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 115

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

AngioDynamics' NanoKnife® System Receives FDA Clearance

Updated Category News Views 191

Introduction to AngioDynamics' Innovation AngioDynamics, Inc. (NASDAQ: ANGO), a forward-thinking medical technology firm, has made significant strides in restoring healthy blood flow and enhancing cancer treatment options. Recently, the company announced its accomplishment in receiving FDA 510(k) clearance for its advanced NanoKnife System, specifically designed for...

Continue Reading
Analyst Predicts iPhone Dominance in Apple's Future Revenues

Updated Category News Views 197

Apple's Revenue Outlook and iPhone Influence A recent analysis by Needham paints a promising picture for Apple Inc (NASDAQ: AAPL) as the company prepares for fiscal year 2025. Analyst Laura Martin affirmed a buy rating for Apple, setting an impressive price target of $260. This forecast is based on a well-crafted Discounted Cash Flow (DCF) model, which includes a cash tax...

Continue Reading
Sitetracker's Record Growth and Vision for Future Success

Updated Category News Views 398

Remarkable Achievements in 2024 for Sitetracker Sitetracker has reached significant milestones marking the close of its fiscal year with outstanding growth and exciting plans for the upcoming year. As a leader in the field of asset lifecycle management, they have positioned themselves strongly in markets worldwide, focusing on providing tools for various critical...

Continue Reading
Olympus Showcases Innovative ENT Solutions at Major Meetings

Updated Category News Views 176

Olympus Highlights Cutting-Edge ENT Solutions Olympus Corporation of the Americas, a leading medical technology company committed to enhancing health and safety, will unveil its extensive ENT portfolio at upcoming annual physician meetings. Attendees will have the opportunity to see how Olympus integrates hybrid endoscopy with advanced imaging and content management...

Continue Reading
Exciting Launch of Tech Mahindra Chess League Season 3

Updated Category News Views 101

Tech Mahindra Global Chess League Season 3 Launches with Excitement The Global Chess League (GCL) has officially begun its Season 3, and excitement fills the air as six teams are set to compete in 34 matches for the coveted championship trophy. The league kicked off at Mumbai's Royal Opera House, a perfect venue for this grand event. Spectacular Opening Ceremony in Mumbai...

Continue Reading